US Stock MarketDetailed Quotes

TNXP Tonix Pharmaceuticals

Watchlist
  • 11.9500
  • +0.5200+4.55%
Close Feb 14 16:00 ET
  • 12.1800
  • +0.2300+1.92%
Pre 08:42 ET
66.81MMarket Cap0.00P/E (TTM)

Tonix Pharmaceuticals Key Stats

Tonix Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.200M--
--2024/Q4-- / 3.200M--
--2024/Q32.822M / 3.150M--
Aug 14, 20242024/Q22.208M / 3.500M--
--2024/Q12.482M / 3.867M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.200M--
--2024/Q4-- / 3.200M--
--2024/Q32.822M / 3.150M--
Aug 14, 20242024/Q22.208M / 3.500M--
--2024/Q12.482M / 3.867M--

Unlock Free Earnings Estimates

Tonix Pharmaceuticals Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 5, 2025

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data